← Evidence map

ArticleCancers2022

The Novel IGF-1R Inhibitor PB-020 Acts Synergistically with Anti-PD-1 and Mebendazole against Colorectal Cancer.

Bo Kang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

8 papers cite it

2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 36497233